Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria

Wenyi Shen, Michael J. Clemente, Naoko Hosono, +8

Journal of Clinical Investigation

Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1

Peng Liu, Baoshan Xu, Wenyi Shen, +9

Leukemia

CytokineChronic Lymphocytic LeukemiaCell RegulationMedicineApoptosis +10

Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia

Hassan Awada, Yasunobu Nagata, Abhinav Goyal, +18

Blood Advances

A Novel Long Non-coding RNA, MSTRG.51053.2 Regulates Cisplatin Resistance by Sponging the miR-432-5p in Non-small Cell Lung Cancer Cells

Jie Zhang, Chuanqin Xu, Y Gao, +5

Frontiers in Oncology

Downregulated <scp>D</scp>icer expression predicts poor prognosis in chronic lymphocytic leukemia

Danxia Zhu, Lei Fan, Ruinan Lu, +9

Cancer Science

Hematological MalignancyLymphoid NeoplasiaOncologyChronic Lymphocytic LeukemiaMedicine +13

High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid

Wei Wu, Huayuan Zhu, Yuan Fu, +8

Oncotarget

Ethacrynic AcidMixed-phenotype Acute LeukemiaImmunologyPathologyCell Death +17

Zebrafish xenograft model of human lung cancer for studying the function of LINC00152 in cell proliferation and invasion

Wenyi Shen, Juan Pu, Jing Sun, +5

Cancer Cell International

The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1

Wenyi Shen, Juan Pu, Zhi Zuo, +6

Cancer Cell International

Clinical significance of down-regulated cylindromatosis gene in chronic lymphocytic leukemia

Wei Wu, Huayuan Zhu, Yuan Fu, +7

Leukemia & lymphoma/Leukemia and lymphoma

Cyld LowMixed-phenotype Acute LeukemiaImmunologyPathologyMolecular Genetics +16

&lt;p&gt;Circular RNA Circ-ZNF609 Promotes Lung Adenocarcinoma Proliferation by Modulating miR-1224-3p/ETV1 Signaling&lt;/p&gt;

Yangsong Zuo, Wenyi Shen, Chengshi Wang, +2

Cancer Management and Research